ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation – MLTX
NEW YORK CITY, NY / ACCESS Newswire / October 4, 2025 / WHY: New York, N.Y., October 4, 2025. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MoonLake Immunotherapeutics (NASDAQ:MLTX) resulting from allegations that MoonLake may have issued materially misleading business information […]